Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

iCo Therapeutics Inc Announces To Raise $3.2 Million


Friday, 10 May 2013 10:19am EDT 

iCo Therapeutics Inc announced that it has priced its previously announced overnight marketed offering (the Offering). Pursuant to the Offering, iCo will issue an aggregate of 9,170,000 units (Units) at a price of $0.35 per unit for aggregate gross proceeds of $3,209,500. Each Unit includes one common share and one common share purchase warrant (a Warrant). Each Warrant is exercisable at a price of $0.40 for a period of five years from the closing of the Offering. Euro Pacific Canada Inc. acted as agent in respect of the Offering, with H.C. Wainwright & Co. LLC and Bloom Burton & Co. as part of the selling group. H.C. Wainwright & Co. LLC acted as lead U.S. placement agent. The selling group will be paid a cash commission equal to 8% of the gross proceeds of the Offering (except in respect of Units issued to certain specified purchasers, in which case the cash commission will be reduced to 4%) and will receive that number of compensation warrants (Compensation Warrant) which is equal to 5% of the number of Units sold pursuant to the Offering (except in respect of Units issued to certain specified purchasers, in which case the number of Compensation Warrants to be issued to the selling group will be reduced to 2.5%). The Compensation Warrants will have the same terms and conditions as the Warrants to be included in the Units. 

Company Quote

0.07
0.0 +0.00%
28 Aug 2014